Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

BRENDA Home
show all | hide all No of entries

Information on EC 3.4.23.50 - human endogenous retrovirus K endopeptidase and Organism(s) Homo sapiens and UniProt Accession P10265

for references in articles please use BRENDA:EC3.4.23.50
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
EC Tree
Specify your search results
Select one or more organisms in this record: ?
This record set is specific for:
Homo sapiens
UNIPROT: P10265 not found.
Show additional data
Do not include text mining results
Include (text mining) results
Include results (AMENDA + additional results, but less precise)
The taxonomic range for the selected organisms is: Homo sapiens
The enzyme appears in selected viruses and cellular organisms
Reaction Schemes
Processing at the authentic HIV-1 PR recognition site and release of the mature p17 matrix and the p24 capsid protein, as a result of the cleavage of the -SQNY-/-PIVQ- cleavage site.
Synonyms
herv-k pr, herv-k(hml-2) pro, herv-k protease, herv-k(hml-2) protease, more
SYNONYM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
endogenous retrovirus HERV-K10 putative protease
-
-
-
-
HERV K10 endopeptidase
-
-
-
-
HERV K10 retropepsin
-
-
HERV-K PR
-
-
-
-
HERV-K protease
HERV-K113 protease
-
-
human endogenous retrovirus K retropepsin
-
-
-
-
human endogenous retrovirus K113 protease
-
-
human retrovirus K10 retropepsin
-
-
additional information
-
the enzyme belongs to the human endogenous retrovirus family HERV-K/HML-5
REACTION
REACTION DIAGRAM
COMMENTARY hide
ORGANISM
UNIPROT
LITERATURE
Processing at the authentic HIV-1 PR recognition site and release of the mature p17 matrix and the p24 capsid protein, as a result of the cleavage of the -SQNY-/-PIVQ- cleavage site.
show the reaction diagram
the enzyme contains the aspartic protease triad Asp-Thr-Gly in the catalytic site
-
REACTION TYPE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
hydrolysis of peptide bond
-
-
-
-
CAS REGISTRY NUMBER
COMMENTARY hide
144114-21-6
-
SUBSTRATE
PRODUCT                       
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate) hide
LITERATURE
(Substrate)
COMMENTARY
(Product) hide
LITERATURE
(Product)
Reversibility
r=reversible
ir=irreversible
?=not specified
2-aminobenzoyl-Ala-Thr-His-Gln-Val-Tyr-Phe(NO2)-Val-Arg-Lys-Ala + H2O
?
show the reaction diagram
-
-
-
-
?
2-aminobenzoyl-ATHQVY-(4-nitro)FVRKA + H2O
2-aminobenzoyl-ATHQVY + (4-nitro)FVRKA
show the reaction diagram
-
-
-
-
?
Gag polyprotein + H2O
?
show the reaction diagram
-
the enzyme is synthesized as part of the Gag polyprotein or the Gag-Pol polyprotein and autolytically processed to the mature dimer
-
-
?
Gag-Pol polyprotein + H2O
?
show the reaction diagram
-
the enzyme is synthesized as part of the Gag polyprotein or the Gag-Pol polyprotein and autolytically processed to the mature dimer
-
-
?
HERV-K Gag polyprotein + H2O
?
show the reaction diagram
HIV-1 matrix-capsid polyprotein + H2O
?
show the reaction diagram
KARVY-(4-nitro)FEA-Nle-NH2 + H2O
KARVY + (4-nitro)FEA-Nle-NH2
show the reaction diagram
-
-
-
-
?
Lys-Ala-Arg-Val-Tyr-Phe(NO2)-Glu-Ala-Nle-NH2 + H2O
?
show the reaction diagram
-
-
-
-
?
additional information
?
-
NATURAL SUBSTRATE
NATURAL PRODUCT
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate) hide
LITERATURE
(Substrate)
COMMENTARY
(Product) hide
LITERATURE
(Product)
REVERSIBILITY
r=reversible
ir=irreversible
?=not specified
Gag polyprotein + H2O
?
show the reaction diagram
-
the enzyme is synthesized as part of the Gag polyprotein or the Gag-Pol polyprotein and autolytically processed to the mature dimer
-
-
?
Gag-Pol polyprotein + H2O
?
show the reaction diagram
-
the enzyme is synthesized as part of the Gag polyprotein or the Gag-Pol polyprotein and autolytically processed to the mature dimer
-
-
?
additional information
?
-
METALS and IONS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
NaCl
-
1 M, activates
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
ABT538
-
-
indinavir
KNI227
-
-
KNI272
-
-
L735,524
-
-
pepstatin
pepstatin A
Q8467
-
-
ritonavir
Ro31-8624
-
-
Ro31-8959
-
-
saquinavir
SD145
-
-
SD146
SD152
-
-
XK234
-
-
XM412
-
-
XV638
-
-
XV643
-
-
XV644
-
-
XV648
-
-
XV651
-
-
XV652
-
-
XW805
-
-
additional information
-
the enzyme is highly resistant to all the HIV-1 PR inhibitors tested, including L-735,524, Ro31-8959, and ABT 538
-
ACTIVATING COMPOUND
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
additional information
-
high ionic strength activates the enzyme
-
KM VALUE [mM]
SUBSTRATE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.002 - 0.041
2-aminobenzoyl-Ala-Thr-His-Gln-Val-Tyr-Phe(NO2)-Val-Arg-Lys-Ala
0.001 - 0.0103
Lys-Ala-Arg-Val-Tyr-Phe(NO2)-Glu-Ala-Nle-NH2
TURNOVER NUMBER [1/s]
SUBSTRATE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.13 - 1.37
2-aminobenzoyl-Ala-Thr-His-Gln-Val-Tyr-Phe(NO2)-Val-Arg-Lys-Ala
0.8 - 2.1
Lys-Ala-Arg-Val-Tyr-Phe(NO2)-Glu-Ala-Nle-NH2
Ki VALUE [mM]
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.00006
ABT538
-
pH 4.5, 11600 Da core domain
0.00061 - 0.00094
indinavir
0.0000046 - 0.000015
KNI227
0.00012 - 0.00034
KNI272
0.00257 - 0.0049
pepstatin
0.0000162 - 0.000061
Q8467
0.00113 - 0.00121
ritonavir
0.00258 - 0.00574
saquinavir
0.0000059 - 0.00003
SD145
0.00000015 - 0.0000043
SD146
0.0000079 - 0.000027
SD152
0.00067 - 0.00187
XK234
0.000091 - 0.00039
XM412
0.0000022 - 0.00002
XV638
0.00000017 - 0.0000039
XV643
0.00000022 - 0.0000029
XV644
0.0000001 - 0.0000023
XV648
0.0000032 - 0.000043
XV651
0.00000052 - 0.0000033
XV652
0.0000036 - 0.000031
XW805
additional information
additional information
-
-
-
pH OPTIMUM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
4 - 5
-
11600 Da core domain
4.5
-
C-terminally truncated mutant enzyme, substrate KARVYF-NO2-EA-Nle-NH2
ORGANISM
COMMENTARY hide
LITERATURE
UNIPROT
SEQUENCE DB
SOURCE
-
SwissProt
Manually annotated by BRENDA team
UNIPROT
ENTRY NAME
ORGANISM
NO. OF AA
NO. OF TRANSM. HELICES
MOLECULAR WEIGHT[Da]
SOURCE
SEQUENCE
LOCALIZATION PREDICTION?
VPK10_HUMAN
156
0
17108
Swiss-Prot
other Location (Reliability: 3)
MOLECULAR WEIGHT
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
16470
-
avarage molecular weight under near physiological conditions, sedimentation equilibrium analysis
17500
-
2 * 17500, the enzyme is synthesized as monomeric part of the Gag polyprotein or the Gag-Pol polyprotein and autolytically processed to the mature protein dimer, structure overview
43000
-
SDS-PAGE
SUBUNIT
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
dimer
-
2 * 17500, the enzyme is synthesized as monomeric part of the Gag polyprotein or the Gag-Pol polyprotein and autolytically processed to the mature protein dimer, structure overview
additional information
-
the 11600 Da core domain exists as a dimer at pH 7.0
POSTTRANSLATIONAL MODIFICATION
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
proteolytic modification
-
the enzyme is synthesized as monomeric part of the Gag polyprotein or the Gag-Pol polyprotein and autolytically processed to the mature protein dimer, autoprocessing at the N-terminal sequence Lys-Ala-Ala-Tyr-Trp-Ala-Ser-Gln
PROTEIN VARIANTS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
additional information
-
a C-terminally truncated mutant enzyme shows increased affinity for the peptide substrates and increased sensitivity to peptidomimetic inhibitors compared to the wild-type enzyme
pH STABILITY
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
3 - 9
-
room temperature, prolonged incubation, 60% remaining activity in presence or absence of 1 M NaCl, no autolysis
668800
PURIFICATION (Commentary)
ORGANISM
UNIPROT
LITERATURE
18200 Da enzyme form and 11600 Da core domain
-
full-length and C-terminally truncated enzyme in Escherichia coli
-
recombinant wild-type and C-terminally truncated mutant enzymes from Escherichia coli by ammonium sulfate fractionation, cation and anion exchange chromatography, and hydrophobic interaction chromatography, or recombinant C-terminally truncated mutant enzyme from inclusion bodies by dialysis and pepstatin A affinity chromatography followed by autoprocession to active, soluble enzme
-
CLONED (Commentary)
ORGANISM
UNIPROT
LITERATURE
213 amino acids of the 3'-end of the HERV-K protease open reading frame are expressed in Escherichia coli. Autocatalytic cleavage of the expressed polypeptide results in a catalytically active 18200 Da protein
-
expression of a full-length and C-terminally truncated enzyme in Escherichia coli
-
nucleotide sequence determination and analysis, detailed phylogenetic analysis of virus from primates and humans, and structural analysis of 100 HERV-K(HML-5) provirus sequences, reconstruction of a coding-competent HML-5 provirus, overview
-
sequence determination and analysis, expression of wild-type and C-terminally truncated mutant enzymes in Escherichia coli
-
targeting of the HERV-K PR to protease-deficient HIV-1 virions by expressing it as a Vpr fusion partner. The Vpr fusion proteins are sucessfully delivered to the HIV-1 virions, where the HERV-K PR not only autoprocesses itself to ist mature form, but also cleaves a number of HIV-1 polyproteins
-
the enzyme is expressed either as a full-length native protein or as truncated protein in Escherichia coli
-
the HERV-K113 sequence is cloned into a small plasmid vector. It is shown that based on a substantial LTR-promoter activity, full length messenger RNA and spliced env-, rec- and 1.5 kb (hel)-transcripts are produced. Envelope protein of HERV-K113 is synthesized as an 85 kDa precursor that is found partially processed. The accessory Rec protein is highly expressed and accumulates in the nucleus. Expression analysis reveals synthesis of the Gag precursor and the protease in lysates of transfected HEK-293T cells. The cloned HERV-K113 provirus is not replication competent
-
APPLICATION
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
medicine
-
in the present study HIV-1 and HCV-1-positive plasma samples are screened for the presence of HERV-K(HML-2) RNA in an RT-PCR using HERV-K pol specific primers. Type 1 and type 2 HERV-K(HML- 2) viral RNA genomes are found to coexist in the same plasma of HIV-1 patients suggesting that HERV-K(HML-2) viral particles are induced in HIV-1-infected individuals
REF.
AUTHORS
TITLE
JOURNAL
VOL.
PAGES
YEAR
ORGANISM (UNIPROT)
PUBMED ID
SOURCE
Ono M.; Yasunaga T.; Miyata T.; Ushikubo H.
Nucleotide sequence of human endogenous retrovirus genome related to the mouse mammary tumor virus genome
J. Virol.
60
589-598
1986
Homo sapiens (P10265)
Manually annotated by BRENDA team
Towler, E.M.; Gulnik, S.V.; Bhat, T.N.; Xie, D.; Gustschina, E.; Sumpter, T.R.; Robertson, N.; Jones, C.; Sauter, M.; Mueller-Lantzsch, N.; Debouck, C.; Erickson, J.W.
Functional characterization of the protease of human endogenous retrovirus, K10: can it complement HIV-1 protease?
Biochemistry
37
17137-17144
1998
Homo sapiens
Manually annotated by BRENDA team
Kuhelj, R.; Rizzo, C.J.; Chang, C.H.; Jadhav, P.K.; Towler, E.M.; Korant, B.D.
Inhibition of human endogenous retrovirus-K10 protease in cell-free and cell-based assays
J. Biol. Chem.
276
16674-16682
2001
Homo sapiens
Manually annotated by BRENDA team
Padow, M.; Lai, L.; Fisher, R.J.; Zhou, Y.C.; Wu, X.; Kappes, J.C.; Towler, E.M.
Analysis of human immunodeficiency virus type 1 containing HERV-K protease
AIDS Res. Hum. Retroviruses
16
1973-1980
2000
Homo sapiens
Manually annotated by BRENDA team
Schommer, S.; Sauter, M.; Krausslich, H.G.; Best, B.; Mueller-Lantzsch, N.
Characterization of the human endogenous retrovirus K proteinase
J. Gen. Virol.
77
375-379
1996
Homo sapiens
Manually annotated by BRENDA team
Strisovsky, K.; Kraeusslich, H.
Human retrovirus K10 retropepsin
Handbook of Proteolytic Enzymes (Barrett, J. ; Rawlings, N. D. ; Woessner, J. F. , eds. )
1
182-184
2004
Homo sapiens
-
Manually annotated by BRENDA team
Lavie, L.; Medstrand, P.; Schempp, W.; Meese, E.; Mayer, J.
Human endogenous retrovirus family HERV-K(HML-5): status, evolution, and reconstruction of an ancient betaretrovirus in the human genome
J. Virol.
78
8788-8798
2004
Homo sapiens
Manually annotated by BRENDA team
Contreras-Galindo, R.; Kaplan, M.H.; Markovitz, D.M.; Lorenzo, E.; Yamamura, Y.
Detection of HERV-K(HML-2) Viral RNA in Plasma of HIV Type 1-Infected Individuals
AIDS Res. Hum. Retroviruses
22
979-984
2006
Homo sapiens
Manually annotated by BRENDA team
Beimforde, N.; Hanke, K.; Ammar, I.; Kurth, R.; Bannert, N.
Molecular cloning and functional characterization of the human endogenous retrovirus K113
Virology
371
216-225
2008
Homo sapiens
Manually annotated by BRENDA team
Kraus, B.; Boller, K.; Reuter, A.; Schnierle, B.
Characterization of the human endogenous retrovirus K Gag protein: Identification of protease cleavage sites
Retrovirology
8
21
2011
Homo sapiens
Manually annotated by BRENDA team